|
Otolaryngology Q & A
5E UHC
4201 St Antoine
Detroit, MI 48201
Phone (313) 577-0804
Other links
Links to other organizations
Detroit Medical Center
Wayne State University
WSU - School of Medicine
Map
City of Detroit
All Detroit.com
|
|
Grant Funding
Historically, the Department of Otolaryngology has enjoyed relative high levels of outside funding. Presently, grants to various faculty members within the department and the most current, ongoing projects are listed below:
Investigator |
Title |
Number |
Total Project Period |
Current Effort |
Current Direct Costs |
|
|
|
|
|
|
Church M. |
Life-Long Effects of Prenatal Alcohol Exposure |
NIAAA, R01 AA09991 |
09/01/97-08/01/01 |
50% |
$815,255 |
|
|
|
|
|
|
Church M. |
BAEP Screening of Neonates Exposed to Alcohol/Cocaine |
NIAAA, R01 AA10941 |
09/01/97 – 08/01/02 |
50% |
$1,272,131 |
|
|
|
|
|
|
Church M. |
Supplemental Support – BAEP Screening of Neonates |
NIAAA, R01 AA10941-04S1 |
09/01/00 – 08/01/02 |
0% |
$29,800 |
|
|
|
|
|
|
Drescher, DG. |
Identification of Acoustico-Lateralis Transmitters |
R01 DC00156 |
07/01/94 -06/30/98 |
10% |
$539,154 |
Drescher, DG. |
Identification of Acoustico-Lateralis Transmitters |
R01 DC00156 |
07/01/98 -06/30/03 |
20% |
$855,763 |
|
|
|
|
|
|
Drescher, DG |
Adenylyl cyclase Signaling in Ear Sensory Epithelia (PI: Drescher, MJ) |
R01 DC04076 |
05/01/99 - 04/30/03 |
30% |
$461,716 |
|
|
|
|
|
|
Drescher, MJ |
Adenylyl cyclase Signaling in Ear Sensory Epithelia |
R01 DC04076 |
05/01/99 - 04/30/03 |
30% |
$461,716 |
|
|
|
|
|
|
Drescher, MJ. |
Identification of Acoustico-Lateralis Transmitters (PI: Drescher, DG) |
R01 DC00156 |
07/01/98 -06/30/03 |
20% |
$855,763 |
|
|
|
|
|
|
Finlayson, PG |
Modulating Auditory Temporal Processing Through Neuronal Ionic Conductances |
Deafness Research Foundation |
01/01/01 - 12/31/01 |
75% |
$18,173 |
|
|
|
|
|
|
Finlayson, PG |
Second messenger modulation of LSO neuron response |
NIH (NIDCD)
R01 DC04711-01A1 (pending) |
12/01/01 - 11/30/06 |
80% |
$750,000 |
|
|
|
|
|
|
Kaltenbach, J |
Life-Long Effects of Prenatal Alcohol Exposure (PI: Church M) |
NIAAA, R01 AA09991 |
09/01/97-08/01/01 |
25% |
$815,255 |
|
|
|
|
|
|
Kaltenbach, J |
Studies of tinnitus in animals |
Sepracor, Inc. |
04/01/01- 03/31/02 |
25% |
$248,000 |
|
|
|
|
|
|
Kaltenbach, J |
Neural correlates of sound induced tinnitus |
Tinnitus Research Consortium |
07/01/00-06/30/03 |
10% |
$300,000 |
|
|
|
|
|
|
Mathog, R.H. |
Residency Training in Otolaryngology |
NIH T32 DC00026-14 |
07/01/97 -06/30/02 |
30% |
$622,122 |
|
|
|
|
|
|
Monsell, E. |
Volumetric Change in Acoustic Neuroma |
Fund for Henry Ford Hospital |
1995-2001 |
20% |
$210,000 |
|
|
|
|
|
|
Piechocki, M. |
DNA Vaccination to over-come peripheral tolerance (PI: W-Z Wei) |
US Army Department of Defense |
6/01/01-6/01/04 |
10% |
$447,000 |
|
|
|
|
|
|
Piechocki, M |
Development of ERBB-2 Based Breast Cancer Vaccines (PI: W-Z Wei) |
NIH:NCI 5 R01 CA76340-03 |
12/1/97 - 11/30/02 |
0% |
$794,300 |
|
|
|
|
|
|
Yoo, G |
Preventing head & neck tumor progression by restoring cell cycle regulation |
American Cancer Society |
7/1/99 - 6/30/03 |
65% |
$443,000 |
|
|
|
|
5% |
|
Yoo, G |
Antitumor Mechanisms of Docetaxel on Upper Aerodigestive Tract Cells |
Aventis Pharmaceuticals |
6/01/00- 5/31/03 |
|
$250,000 |
|
|
|
|
|
|
Yoo, G. |
Phase II Trial of Surgery with Perioperative Ad-p53 Gene Therapy Followed by Chemoradiotherapy for Advanced, Resectable Squamous Cell Carcinoma of the Oral Cavity and Oropharynx. S0011 |
SWOG & Introgen |
5/1/00-12/30/05 |
5% |
|
|
|
|
|
|
|
Yoo, G. |
Title: A Phase III, Multi-center, Open Label, Randomized Study to Compare the Overall Survival and Safety of Bi-weekly Intratumoral Administration of RPR/INGN 201 Versus Weekly Methotrexate in 240 Patients with Refractory Squamous Cell Carcinoma of the Head and Neck (SCCHN). |
Introgen |
12/01/99-12/30/03
|
5% |
$53,310 |
|
|
|
|
|
|
Yoo, G. |
A Phase III, Multi-Center, Open-Label, Randomized Study to Compare the Effectiveness and Safety of Intratumoral Administration of RPR/INGN 201 in Combination with Chemotherapy Versus Chemotherapy Alone in 288 Patients with Recurrent Squamous Cell Carcinoma of the Head and Neck |
Introgen |
03/01/00-12/30/04 |
5% |
$58,310 |
|
|
|
|
|
|
Zhang, Z. |
Neural Correlates of Sound - Induced Tinnitus |
Tinnitus Research Consortium |
07/01/01 - 06/30/03 |
65% |
$ 300,000 |
|
|
|
|
|
|
Zhang, Z. |
Neural Mechanisms of Tinnitus |
University Research Grant Program |
05/01/01-04/30/02 |
5% |
$7,000 |
Grants-2000
- Dennis Drescher, Ph.D., Marian Drescher, Ph.D.-NIH, "Identification of Acoustico-Lateralis Transmitters", $253,835.
- George Yoo, M.D.-Aventis Pharmaceuticals, "Antitumor Mechanisms of Docetaxel on Upper Aerodigestive Tract Cells", $250,000.
- James Kaltenbach, Ph.D.-NIH "Central Mechanisms Related to Tinnitus", $330,3888
- George Yoo, M.D.-Target Genetics Corporation, "EIA Phase II Study", $30,000.
Grants-1999
- George H. Yoo, M.D.-American Cancer Society, "Preventing Head and Neck Tumor Progression", $443,000.
- Walter Belenkey, M.D.-The Carls Foundation, $3,000,000.
- Marian Drescher, Ph.D. Dennis Drescher, Ph.D.-NIH, "Adenylyl Cyclose Signaling in Ear Sensory Epithelia", $733,026.
- Robert H. Mathog, M.D.-NIH "Research Training in Otolaryngology" $125.916
- James E. Kaltenbach, Ph.D.-NIDCD (RO1), "Central Mechanisms Related to Tinnitus", $1,874,829.
- James E. Kaltenbach, Ph.D.-Speracor, "Studies of Tinnitus in Animals", $124,000.
Grants-1998
- Robert H. Mathog, M.D.-NIH, "Research Training in Otolaryngology", $128,257.
- George H. Yoo, M.D.-American Cancer Society, "Preventing Head and Neck Tumor Progression", $20,000.
- George H. Yoo, M.D.-Targeted Genetics, "EIA Lipid Phase II Study", $10,000.
- Dennis Drescher, Ph.D.-NIH, "Identification of Acoustico-lateralis Transmitters", $327,000.
- James Kaltenbach, Ph.D.-Pfizer, "The Role of Gaba Receptors in the Modulation of Hearing Thresholds", $185,000.
Grants-1997
- Robert H. Mathog,M.D.-NIDCD (T32), "Research Training in Otolaryngology", $125,647.
- Dennis G. Drescher, Ph.D.,-NIH, "Identification of Acoustico-Lateralis Transmitters", $202,291.
- Wayne S. Quirk, Ph.D., NIH (R29), "Sound-Induced Changes in Cochlear Blood Flow", $109,670.
- James Kaltenbach, Ph.D.-NIHI (R21), "Central Mechanisms Related to Tinnitus", $142,220.
- James Kaltenbach, Ph.D.-Pfizer, "Mechanisms of Noise-Induced Tinnitus", $100,407.
- George H. Yoo, M.D.-RPR Gencell, "Ad-p53 phase II gene therapy trial", $150,913.
- George H. Yoo, M.D.-Targeted Genetics, "Phase 1 E1a Gene Therapy Trial", $83,295.
- Pavan Reddy, M.D.-American Academy of Otolaryngology, "Regulation of Vestibular Blood Flow", $9,900.
- Terry Shibuya, M.D.-American Cancer Society, "Assessment of Immunologic Reactivity in HNSCC Patients", $11,750.
Grants-1996
- Robert H. Mathog Research Training in Otolaryngology N1H CDRC 2 T32 DC00026-08 $156,439
- Dennis G. Drescher Principal Investigator-Identification of Accoustico-Lateralis Transmitters N1H 5 RO1 DG00156-16 $194,501
- Wayne S. Quirk Principal Investigator-Sound-Induced Changes in Cochlear Blood Flow NIH 5 R29 DC01745-4 $115,280
- James Kaltenbach Principal Investigator-Spontaneous Activity and Neuro Chem American tinnitus Society $30,000
- Timothy Doerr Regulatory Mechanisms of Vestibular Blood Flow American Otolaryngical Society Research Fund ` $39,621
top
|
